Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Cryo Cell International (CCEL) Shares Repurchased (2016 - 2025)

Cryo Cell International's Shares Repurchased history spans 11 years, with the latest figure at $80883.0 for Q3 2025.

  • Quarterly results put Shares Repurchased at $80883.0 for Q3 2025, up 393.19% from a year ago — trailing twelve months through Nov 2025 was $169502.0 (down 88.1% YoY), and the annual figure for FY2025 was $169502.0, down 88.1%.
  • Shares Repurchased for Q3 2025 was $80883.0 at Cryo Cell International, down from $88619.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $1.2 million in Q2 2024 to a low of $7584.0 in Q3 2023.
  • The 5-year median for Shares Repurchased is $243201.0 (2023), against an average of $343207.8.
  • The sharpest move saw Shares Repurchased tumbled 97.16% in 2023, then skyrocketed 393.19% in 2025.
  • Year by year, Shares Repurchased stood at $249377.0 in 2021, then plummeted by 48.88% to $127482.0 in 2022, then tumbled by 94.05% to $7584.0 in 2023, then surged by 116.24% to $16400.0 in 2024, then skyrocketed by 393.19% to $80883.0 in 2025.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $80883.0, $88619.0, and $16400.0 for Q3 2025, Q2 2025, and Q3 2024 respectively.